THCVC₁₉H₂₆O₂

Clinical Overview of Tetrahydrocannabivarin

CB1 antagonist (low dose), CB1 agonist (high dose), CB2 partial agonist

Key Action

Metabolic regulation, glycemic stabilizer, and clean mental lucidity.

Clinical Abstract

Tetrahydrocannabivarin (THCV) is a rare propyl cannabinoid that differs from THC by having a shorter 3-carbon side chain. This slight structural variation alters its pharmacological activity. At low clinical dosages, THCV acts as a neutral antagonist at CB1 receptors. By blocking CB1, it suppresses appetite and speeds up metabolic rate—reversing the hunger-inducing effects typical of THC. THCV also modulates glucose tolerance and enhances insulin sensitivity, making it a subject of research for metabolic health. Clinically, THCV provides a highly clear, energetic focus without any intoxicating drag.

Physiological Mechanisms of Action

CB1 Receptor BlockadeCurbs cravings, regulates satiety, and supports healthy metabolism.

Beta-Cell PreservationSupports pancreatic insulin secretion and glucose disposal.

Hypothalamic ActivationEnhances basic energetic drive and sensory response speeds.

CB2 ModulationSafeguards peripheral organs from chronic inflammatory decay.

Target Clinical Indications

Satiety control and appetite moderation

Insulin sensitivity and glycemic stabilization

Severe brain fog and cognitive lethargy

Low-energy fatigue states

Dosing & Titration Protocols (“Start Low and Go Slow”)

Consume 5mg to 7.5mg of THCV in the morning before eating. Avoid evening use as its highly energizing properties can interfere with sleep. Increase by 2.5mg if focus or appetite-suppression targets are not met.

Entourage Synergies & Secondary Phyto-coupling

LimoneneEnhances cellular energy, raising mood and alertness.

PineneWorks to maximize executive brain functions and study stamina.

CBGCombines with THCV to form an ultimate non-jittery cognitive focus blend.

Medical Study Source Citations: